Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction

Source
Gastroenterology - ISSN 0016-5085-167:2 (2024) p. 1-20
Author(s)

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα

Source
Metabolism: clinical and experimental - ISSN 0026-0495-151 (2024) p. 1-14
Author(s)
    Ludivine Clavreul, Lucie Bernard, Alexia K. Cotte, Nathalie Hennuyer, Cyril Bourouh, Claire Devos, Audrey Helleboid, Joel T. Haas, An Verrijken, Celine Gheeraert, Bruno Derudas, Loic Guille, Julie Chevalier, Jerome Eeckhoute, Emmanuelle Vallez, Emilie Dorchies, Luc Van Gaal, Guillaume Lassailly, Sven Francque, Bart Staels, Rejane Paumelle

Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis

Source
Journal of hepatology - ISSN 0168-8278-79:4 (2023) p. 1-13
Author(s)
    Fanny Lalloyer, Denis A. Mogilenko, An Verrijken, Joel T. Haas, Antonin Lamaziere, Mostafa Kouach, Amandine Descat, Sandrine Caron, Emmanuelle Vallez, Bruno Derudas, Celine Gheeraert, Eric Bauge, Gaetan Despres, Eveline Dirinck, Anne Tailleux, David Dombrowicz, Luc Van Gaal, Jerome Eeckhoute, Philippe Lefebvre, Jean-Francois Goossens, Sven Francque, Bart Staels